Pharmaceutical aerosol product for administration by oral or nasal inhalation

Number of patents in Portfolio can not be more than 2000

United States of America

PATENT NO 11992556
SERIAL NO

17319655

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

This invention relates to a pharmaceutical aerosol product suitable for administration by oral or nasal inhalation and its use in the treatment of respiratory diseases, in particular in the treatment of children. The aerosol composition comprises ciclesonide, ethanol and either 1, 1, 1, 2-tetrafluoroethane, or 1, 1, 1, 2, 3, 3, 3-heptafluoropropane.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
COVIS PHARMA B VOUDE UTRECHTSEWEG 32 3743 KN BAARN

International Classification(s)

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Bauer, Andrea North Reading, US 8 52
Bildmann, Ulrich Hilzingen, DE 3 2
Engelstätter, Renate Allensbach, DE 2 0
Müller, Helgert Radolfzell, DE 6 1
McGlynn, Paul Northborough, US 21 28

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
3.5 Year Payment $1600.00 $800.00 $400.00 Nov 28, 2027
7.5 Year Payment $3600.00 $1800.00 $900.00 Nov 28, 2031
11.5 Year Payment $7400.00 $3700.00 $1850.00 Nov 28, 2035
Fee Large entity fee small entity fee micro entity fee
Surcharge - 3.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 7.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00